Lund-based digital-hematology pioneer with a Portuguese-language market page and named customer-support manager serving PT laboratory customers.
CellaVision AB (STO: CEVI), founded in Lund in 1994 and spun out of Lund University, is the market leader in digital hematology — AI-assisted microscopy that replaces manual differential counts of blood cells in hospital and reference laboratories. The company publishes a dedicated Portuguese market page on cellavision.com/pt-PT with named customer-support personnel for the Portuguese territory, making it one of the more committed Nordic diagnostic vendors in Portugal.
Portuguese clinical pathology laboratories have adopted CellaVision's DC-1, DM1200 and DM9600 analyzers through a mix of partner distribution and direct account management. The systems are typically deployed in larger hospital labs and private reference-lab chains like Unilabs (which itself has Swiss-Nordic roots) and Synlab.
Portugal's clinical laboratory market is consolidating — the national SNS is investing in digital pathology and larger private chains (Unilabs, Synlab, Germano de Sousa) are centralising high-volume hematology. That shift favours vendors like CellaVision that bundle AI-assisted cell classification with remote review — a natural fit for lab networks operating across Lisbon, Porto and the regional hubs.
Fractio helps Nordic companies enter the Portuguese market — from market sizing to first sales, hiring, and legal setup.
Talk to Fractio →